These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36817217)

  • 1. 2D-QSAR, molecular docking, drug-likeness, and ADMET/pharmacokinetic predictions of some non-small cell lung cancer therapeutic agents.
    Ibrahim MT; Uzairu A
    J Taibah Univ Med Sci; 2023 Apr; 18(2):295-309. PubMed ID: 36817217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational modelling studies of some 1,3-thiazine derivatives as anti-influenza inhibitors targeting H1N1 neuraminidase via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions.
    Abdullahi M; Uzairu A; Shallangwa GA; Mamza PA; Ibrahim MT
    Beni Suef Univ J Basic Appl Sci; 2022; 11(1):104. PubMed ID: 36000144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic profiling of quinazoline-4(3H)-one analogs as EGFR inhibitors: 3D-QSAR modeling, molecular docking studies and the design of therapeutic agents.
    Abdullahi SH; Uzairu A; Shallangwa GA; Uba S; Umar AB
    J Taibah Univ Med Sci; 2023 Oct; 18(5):1018-1029. PubMed ID: 36959916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Potent Small-Molecule PCSK9 Inhibitors Based on Quantitative Structure-Activity Relationship, Pharmacophore Modeling, and Molecular Docking Procedure.
    Mahmoudi A; Butler AE; Banach M; Jamialahmadi T; Sahebkar A
    Curr Probl Cardiol; 2023 Jun; 48(6):101660. PubMed ID: 36841313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-silico modelling studies of 5-benzyl-4-thiazolinone derivatives as influenza neuraminidase inhibitors via 2D-QSAR, 3D-QSAR, molecular docking, and ADMET predictions.
    Abdullahi M; Uzairu A; Shallangwa GA; Mamza PA; Ibrahim MT
    Heliyon; 2022 Aug; 8(8):e10101. PubMed ID: 36016519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D-QSAR and docking studies on ursolic acid derivatives for anticancer activity based on bladder cell line T24 targeting NF-kB pathway inhibition.
    Yadav D; Nath Mishra B; Khan F
    J Biomol Struct Dyn; 2019 Sep; 37(14):3822-3837. PubMed ID: 30261824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of potent aldose reductase inhibitors as antidiabetic (Anti-hyperglycemic) agents using QSAR based virtual Screening, molecular Docking, MD simulation and MMGBSA approaches.
    Bakal RL; Jawarkar RD; Manwar JV; Jaiswal MS; Ghosh A; Gandhi A; Zaki MEA; Al-Hussain S; Samad A; Masand VH; Mukerjee N; Nasir Abbas Bukhari S; Sharma P; Lewaa I
    Saudi Pharm J; 2022 Jun; 30(6):693-710. PubMed ID: 35812153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel CDK 9 inhibitors based on virtual screening, molecular dynamics simulation, and biological evaluation.
    Wu M; Han J; Liu Z; Zhang Y; Huang C; Li J; Li Z
    Life Sci; 2020 Oct; 258():118228. PubMed ID: 32781071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico analysis of noscapine compounds as anti-tumor agents targeting the tubulin receptor.
    Nulamuga B; Uzairu A; Babalola IT; Ibrahim MT; Umar AB
    J Taibah Univ Med Sci; 2023 Feb; 18(1):32-44. PubMed ID: 36398020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-based drug design of quinazolin-4(3H)-ones as breast cancer inhibitors using QSAR modeling, molecular docking, and pharmacological profiling.
    Abdullahi SH; Uzairu A; Shallangwa GA; Uba S; Umar AB
    J Egypt Natl Canc Inst; 2023 Aug; 35(1):24. PubMed ID: 37544974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand based-design of potential schistosomiasis inhibitors through QSAR, homology modeling, molecular dynamics, pharmacokinetics, and DFT studies.
    Ja'afaru SC; Uzairu A; Chandra A; Sallau MS; Ndukwe GI; Ibrahim MT; Qamar I
    J Taibah Univ Med Sci; 2024 Apr; 19(2):429-446. PubMed ID: 38440085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Natural Inhibitors against Human Liver Cancer Cell Lines through QSAR, Molecular Docking and ADMET Studies.
    Alam S; Nasreen S; Ahmad A; Darokar MP; Khan F
    Curr Top Med Chem; 2021; 21(8):686-695. PubMed ID: 33280598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the potential of 2-arylbenzimidazole scaffolds as novel α-amylase inhibitors: QSAR, molecular docking, simulation and pharmacokinetic studies.
    Aminu KS; Uzairu A; Chandra A; Singh N; Abechi SE; Shallangwa GA; Umar AB
    In Silico Pharmacol; 2024; 12(1):29. PubMed ID: 38617707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computer-aided drug design and virtual screening of targeted combinatorial libraries of mixed-ligand transition metal complexes of 2-butanone thiosemicarbazone.
    Khan T; Ahmad R; Azad I; Raza S; Joshi S; Khan AR
    Comput Biol Chem; 2018 Aug; 75():178-195. PubMed ID: 29883916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure based virtual screening, 3D-QSAR, molecular dynamics and ADMET studies for selection of natural inhibitors against structural and non-structural targets of Chikungunya.
    Vora J; Patel S; Sinha S; Sharma S; Srivastava A; Chhabria M; Shrivastava N
    J Biomol Struct Dyn; 2019 Aug; 37(12):3150-3161. PubMed ID: 30114965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating network pharmacology and computational biology to propose Yiqi Sanjie formula's mechanisms in treating NSCLC: molecular docking, ADMET, and molecular dynamics simulation.
    Wang Y; He G; Zloh M; Shen T; He Z
    Transl Cancer Res; 2024 Jul; 13(7):3798-3813. PubMed ID: 39145086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-silico studies to recognize repurposing therapeutics toward arginase-I inhibitors as a potential onco-immunomodulators.
    Zaki MEA; Al-Hussain SA; Al-Mutairi AA; Samad A; Ghosh A; Chaudhari S; Khatale PN; Ajmire P; Jawarkar RD
    Front Pharmacol; 2023; 14():1129997. PubMed ID: 37144217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical Characterization,
    Ansari JA; Ahmad MK; Fatima N; Azad I; Mahdi AA; Satyanarayan GNV; Ahmad N
    Anticancer Agents Med Chem; 2022; 22(20):3416-3437. PubMed ID: 35125087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Computational Studies of bis-2-Oxoindoline Succinohydrazides and their In Vitro Cytotoxicity.
    Jarapula R; Badavath VN; Rekulapally S; Manda S
    Curr Comput Aided Drug Des; 2020; 16(3):270-280. PubMed ID: 30652647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3D-QSAR studies on Maslinic acid analogs for Anticancer activity against Breast Cancer cell line MCF-7.
    Alam S; Khan F
    Sci Rep; 2017 Jul; 7(1):6019. PubMed ID: 28729623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.